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between vitamin consumption and all-cause, cardiovascular 
(CVD) disease and cancer mortality.
Results In multivariable-adjusted analyses, there were 
no clear inverse associations between antioxidant vitamin 
intakes and mortality, although in some groups, several 
hazard ratios (HRs) were significant. For example, in men, 
compared with the lowest quintile of vitamin C intake, all-
cause mortality in the third and fourth quintiles was lower 
by 28 % (HR 0.72; 95 % CI 0.61–0.85) and by 20 % (HR 
0.80; 95 % CI 0.68–0.95), respectively. CVD mortality was 
lower by 35 % (HR 0.65; 95 % CI 0.50–0.84) and by 23 % 
(HR 0.77; 95 % CI 0.59–0.99) in third and fourth quintile 
of vitamin C intake, respectively. In women, the third and 
fourth quintiles of dietary intake of vitamin E were asso-
ciated with reduced risk of all-cause death by 33 % (HR 
0.67; 95 % CI 0.53–0.84) and by 23 % (HR 0.77; 95 % CI 
0.61–0.97), respectively. Consumption of vitamin C, vita-
min E and beta-carotene was not related to CVD mortality 
in women and to cancer mortality in either gender.
Conclusion This large prospective cohort study in CEE 
populations with low prevalence of vitamin supplementa-
tion did not find a strong, dose–response evidence for pro-
tective effects of antioxidant vitamin intake.
Keywords Antioxidant vitamin · Mortality · 
Cardiovascular · Central and Eastern Europe
Introduction
Mortality in Central and Eastern European (CEE) countries 
decreased in the last two decades, but it is still higher than 
in Western Europe [1]. Since the main causes of deaths 
are CVD and cancer, modifiable risk factors, such as die-
tary habits, may play an important role in the etiology of 
Abstract 
Purpose The aim of the study was to assess the relation-
ships between individual-level dietary intakes of antioxi-
dant vitamins C, E and beta-carotene with all-cause and 
cause-specific mortality in three Central and Eastern Euro-
pean (CEE) populations.
Methods Data from the Health, Alcohol and Psychoso-
cial factors in Eastern Europe cohort study were used. At 
the baseline survey, between 2002 and 2005, 28,945 men 
and women aged 45–69 years were examined in Novosi-
birsk (Russia), Krakow (Poland) and seven Czech towns. 
Deaths in the cohorts were identified through mortality reg-
isters. Cox regression was used to estimate the association 
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chronic diseases and their association with survival. Socio-
economic transition in CEE countries in the 1990s caused 
significant changes in food consumption, which may have 
an impact on health and life expectancy [2]. Antioxidants 
have been hypothesized to extend the lifespan [3]. Vitamin 
C, vitamin E and provitamin A carotenoids (primarily beta-
carotene), which are essential antioxidants in diet, may pre-
vent oxidative damages by counteracting the effects of free 
radicals [4–6]. Antioxidant vitamins are present in a variety 
of foods. Fruits, particularly citrus fruits, and vegetables 
are rich in vitamin C. Most dietary beta-carotene comes 
from orange and yellow vegetables, dark green leafy vege-
tables, fruits and some vegetable oils. Vitamin E is found in 
vegetable oils, nuts, wheat germ, seeds, green leafy vegeta-
bles, and also eggs, milk and meat and their products [7–9]. 
Despite dietary patterns based on foods with high antioxi-
dant contents having been demonstrated to exert beneficial 
effects on human health [10, 11], most interventional stud-
ies found no association between vitamin supplements and 
mortality [12, 13]. In observational studies, high dietary 
intake of antioxidant vitamins has been associated with 
decreased risk of all-cause [7, 14, 15] and CVD death [7, 
8, 15–18], but this relationship was not confirmed in all 
studies [19–22]. Evidence on the relationship between the 
intake of antioxidant vitamins and the risk of cancer is 
ambiguous [7, 19, 23, 24]. The inconsistent results may 
be due to different methods of vitamin intake assessment, 
large within- and between-individual variation in nutrient 
intake, differences in the age of participants or the variation 
in confounding factors related to social and lifestyle char-
acteristics of study subjects considered [25].
It is possible that the association between vitamin intake 
and potential confounders differs by societies, so analysis 
in a variety of social contexts could help to understand the 
relation between natural vitamins intake and mortality. In 
CEE populations, the structure of potential confounders 
is different than in most previous observational studies in 
economically advanced populations of Western Europe and 
other parts of the world. For example, in CEE, the propor-
tion of economically disadvantaged people is higher than 
in Western Europe, and the prevalence of vitamin supple-
mentation is lower [26, 27]. Additionally, exposure to other 
lifestyle risk factors, such as smoking or alcohol drinking, 
is different compared to Western Europe [28, 29].
Only a few cross-sectional and ecological studies have 
explored dietary antioxidant consumption in CEE coun-
tries, [2, 26, 27, 30–32] and there is no evidence from pro-
spective studies of an association between the individual 
dietary consumption of antioxidant vitamins and mortality 
in this region. The aim of the present study was to assess 
the relationship between dietary intake of antioxidant vita-
mins C, E and beta-carotene with all-cause, CVD and can-
cer mortality in three CEE urban population samples.
Materials and methods
Study populations
We used data from baseline examination and mortality fol-
low-up of the Health, Alcohol and Psychosocial factors in 
Eastern Europe (HAPIEE) study, which was conducted in 
Novosibirsk (Russia), Krakow (Poland) and seven Czech 
towns (Havirov/Karvina, Jihlava, Usti nad Labem, Liberec, 
Hradec Kralove and Kromeriz). Details of the study design 
have been published elsewhere [33]. At baseline, random 
samples of men and women aged 45–69 years, stratified by 
gender and 5-year age groups, were selected from urban 
population registers (electoral lists in Russia). In Kra-
kow and Czech towns, subjects were first visited at home 
to complete questionnaire and then invited to a clinic for 
examination; in Novosibirsk, both the questionnaires and 
examinations were completed in a clinic. In total, 28,945 
respondents took part in the baseline survey, and the overall 
response rate was 59 % [33]. The study was approved by 
the University College London Hospital Ethics Commit-
tee and by the local ethics committee in each participating 
center. All participants gave written informed consent.
Measurements of vitamin intake
Individual dietary intake of vitamin C, vitamin E, beta-car-
otene and energy was calculated based on a standard food 
frequency questionnaire (FFQ) [2]. FFQs consisted of 136, 
147 and 148 food and drink items, in Czech towns, Novo-
sibirsk and Krakow, respectively. Reliability of local ver-
sion of the questionnaire was checked by back translation 
into English [33]. Country-specific portion size for each 
food was specified, and participants were asked how often, 
on average, they had consumed that amount of a particu-
lar food, with nine responses ranging from “six or more 
times per day” to “never or less than once per month”. In 
the next step, frequency of food consumption was con-
verted into daily food consumption, and daily intake of 
energy and nutrients was then calculated by multiplying the 
frequency of food consumed per day by the nutrient con-
tent of the specified standard portion [2]. The validity of 
the FFQ regarding micronutrient intake data was assessed 
by estimating correlations with plasma biomarker concen-
trations measured in a central laboratory (CTSU, Oxford, 
UK) in a random subsample of participants. The correla-
tions for vitamin C and beta-carotene were similar to other 
published large-scale studies [34]. Regarding vitamin E, 
the energy-adjusted Pearson’s partial correlation coefficient 
between vitamin E intake and alpha-tocopherol plasma 
level was 0.15 in the pooled sample, which was slightly 
lower than the average of 21 previously published similar 
studies [35].
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For the present analysis, we excluded 709 individuals 
with invalid diet data (defined as having missing data on 
more than 50 % of food items or reported extreme values 
of energy intake: <500 kcal/day/>4500 kcal/day in women; 
<800 kcal/day/>5000 kcal/day in men). General informa-
tion on supplementation with vitamins and minerals was 
collected based on the questions: “Do you take any vita-
mins or mineral supplements?” and “If yes, do these sup-
plements contain vitamin C?” Those who declared to use 
supplements containing vitamin C regularly, at least three 
times per week, were classified as users of supplements of 
vitamin C.
Mortality
Data on deaths were obtained by linkage with mortality 
registers. In the Krakow cohort, 716 (6.7 %) individuals 
at baseline did not agree for prospective observation and 
were not followed up. For the present analysis, the follow-
up for vital status was complete until December 31 2010 
in Krakow and Novosibirsk and until December 31 2011 
for Czech towns. Median follow-up time was 8.1 years in 
Czech towns, 6.5 years in Novosibirsk and 7.1 years in 
Krakow. Cause-specific mortality was based on the ICD 
10th revision: I00−I99 for CVD deaths and C00−C97 for 
cancer death. For 527 persons, no information on follow-up 
time was available, and they were excluded in this analy-
sis. The final sample included in the analysis consisted 
of 26,993 individuals, of whom 2371 died during the fol-
low-up period, including 997 CVD deaths and 830 cancer 
deaths.
Potential confounders
At baseline examination, a standard questionnaire was 
used to collect data on age, gender, education (catego-
rized into three groups: university, secondary and lower), 
current smoking (yes/no) and alcohol consumption during 
the last 12 months (g/day), health status (self-reported his-
tory of myocardial infarction, stroke, cancer and diabetes). 
Hypertension was defined as systolic blood pressure ≥140 
or diastolic blood pressure ≥90 mmHg or taking antihy-
pertensive drugs. Based on standardized measurements of 
body weight and height, body mass index (BMI, kg/m2) 
was calculated and categorized into three groups: normal 
(BMI < 25.0), overweight (BMI 25.0–29.9) and obese 
(BMI ≥ 30.0). Hypercholesterolemia was defined as hav-
ing serum total cholesterol level ≥5 mmol/l.
Statistical analysis
Association between intake of antioxidant vitamins and 
all-cause and cause-specific mortality was evaluated by 
Cox proportional hazards regression models. Person-years 
of observation were calculated from the date of baseline 
examination to the date of death or the end of follow-
up, whichever came first. Individuals who were lost to 
follow-up were censored at the last date of contact. The 
proportional hazards assumptions in Cox models were 
checked using Schoenfeld’s test examining interactions 
with log-transformed time to the event and indicating no 
significant violation of the assumption [36]. Country- 
and gender-specific quintiles of energy-adjusted intake 
of vitamins C, E and beta-carotene were made. Dietary 
intakes of vitamins were adjusted for total energy intake 
using the residual method [37]. Bottom quintile of vita-
min intake was used as the reference category. First, 
analyses were made separately by country, and the asso-
ciations between vitamin intakes and mortality were simi-
lar across the countries. Then, the interaction between 
quintiles of each antioxidant vitamin intake and countries 
was assessed by likelihood ratio test, comparing models 
with and without the interaction terms. Significant inter-
actions were detected for men in the models testing influ-
ence of beta-carotene intake on the risk of both all-cause 
and CVD mortality and for women in the model testing 
influence of vitamin C intake on the risk of cancer mor-
tality. In all other cases, no significant interaction was 
observed, and the data from the three centers were pooled. 
In the pooled data, two gender-specific Cox models were 
used: first adjusted for age and country; second addition-
ally adjusted for other potential confounders (education, 
smoking status, alcohol intake, BMI, hypertension, diabe-
tes, hypercholesterolemia, history of CVD or cancer and 
total energy intake).
For cause-specific mortality, individuals who died from 
causes other than those investigated were censored at the 
date of death. Additionally, we fitted models in which 
death from causes other than those investigated was treated 
as a competing risk. These models showed similar asso-
ciations as those observed in non-competing risk models 
for deaths from cardiovascular diseases and cancer, so we 
did not present the results in the tables. Differences in the 
distributions of the studied characteristics between quin-
tiles of vitamin intake were tested by χ2 test for categori-
cal variables. For continuous variables with normal and 
non-normal distribution, ANOVA and Kruskal–Wallis tests 
were used, respectively. To deal with the potential effect of 
reverse causality, additional models were run after exclud-
ing individuals who died within the first 2 years of follow-
up and after excluding participants with history of myocar-
dial infarction or stroke or cancer at baseline. Also, models 
after exclusion of users of vitamin C supplements were 
constructed. Statistica version 10.0 and R version 3.0.2. 
software were used; p < 0.05 was set as the level of statis-
tical significance.
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Results
Baseline characteristics of the studied sample by gen-
der and country are presented in Table 1. During follow-
up, the number of total deaths was 1590 (12.6 %) in men 
and 781 (5.4 %) in women. Number of CVD and cancer 
deaths was 684 (5.4 %) and 527 (4.2 %) in men and 313 
(2.2 %) and 303 (2.1 %) in women, respectively. Total 
energy intake and beta-carotene intake were the highest in 
Novosibirsk and the lowest in Czech towns, while intake of 
vitamin C was the lowest in Novosibirsk and the highest in 
Czech towns. The lowest vitamin E intake was observed in 
Table 1  Baseline descriptive statistics and number of deaths by gender and population
Baseline charac-
teristics
Czech towns Novosibirsk Krakow
Men n = 3793 Women n = 4366 Men n = 4074 Women n = 4946 Men n = 4775 Women n = 5039
Age, mean (SD) 58.6 (7.2) 57.9 (7.1) 58.4 (7.0) 58.1 (7.1) 57.9 (7.0) 57.4 (7.0)
Education (%)
 Primary/voca-
tional
49.8 48.8 33.3 40.3 36.6 28.6
 Secondary 31.8 41.1 34.7 33.2 33.4 44.4
 University 18.4 10.1 32.0 26.5 30.0 27.1
Current smokers 
(%)
26.7 20.7 48.8 9.2 33.8 26.0
BMI (kg/m2), 
mean (SD)
28.3 (4.0) 28.1 (5.0) 26.6 (4.4) 30.2 (5.7) 28.0 (4.0) 28.4 (5.1)
Alcohol (g/day), 
median (q1–q3)
8.5 (1.4–27.3) 0.8 (0.1–3.9) 6.6 (1.2–21.0) 0.7 (0.1–1.1) 2.2 (0.1–8.6) 0.7 (0.1–1.1)
Hypertension (%) 72.9 58.3 63.2 67.0 66.3 55.9
Total cholesterol 
(mmol/l), mean 
(SD)
5.6 (1.0) 5.8 (1.0) 6.0 (1.2) 6.5 (1.3) 5.7 (1.1) 5.9 (1.1)
Diabetes (%) 13.3 10.2 4.1 6.1 13.6 10.1
History of MI or 
stroke (%)
10.6 4.6 14.7 8.6 13.0 6.1
History of cancer 
(%)
4.2 8.2 1.3 4.0 3.3 6.2
Total energy intake 
(kcal/day), mean 
(SD)
2081.3 (670.8) 1940.4 (662.2) 2742.8 (772.7) 2335.0 (688.8) 2259.9 (680.9) 2046.8 (611.5)
Use of supple-
ments with 
vitamin C (%)
14.1 23.0 5.9 14.4 9.9 16.8
Vitamin C  
(mg/day), 
median (q1–q3)
134.4 (90.7–
196.6)
189.0 (123.4–
273.4)
71.2 (52.5–102.4) 89.7 (62.9–136.9) 123.9 (89.9–
174.1)
144.0 (101.1–
204.1)
Vitamin E  
(mg/day), 
median (q1–q3)
8.3 (6.9–10.0) 9.9 (8.2–11.8) 9.8 (8.2–11.7) 11.4 (9.6–13.6) 7.7 (6.5–9.0) 8.1 (6.9–9.4)
Beta-carotene  
(ug/day), median 
(q1–q3)
4528.5 (3295.7–
6358.9)
5560.3 (3965.3–
8969.4)
8662.3 (5770.5–
11,545.9)
10,824.7 (7459.1–
13,684.2)
6918 (4515.9–
9330.3)
8037.5 (5308.9–
10,908.8)
Follow-up time 
(years), mean 
(SD)
7.9 (1.6) 8.1 (1.2) 6.0 (1.6) 6.5 (1.1) 6.9 (1.3) 7.1 (1.0)
Number of deaths 
(%)
447 (11.8) 243 (5.6) 615 (15.1) 255 (5.2) 528 (11.1) 283 (5.6)
Number of CVD 
deaths (%)
166 (4.4) 83 (1.9) 333 (8.2) 135 (2.7) 185 (3.9) 95 (1.9)
Number of cancer 
deaths (%)
186 (4.9) 115 (2.6) 145 (3.6) 74 (1.5) 196 (4.1) 114 (2.3)
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Krakow. The proportion of participants with university edu-
cation was similar in Novosibirsk and Krakow and lower 
in Czech towns. In Novosibirsk, the proportion of smok-
ing men was the highest, and the proportion of smoking 
women was the lowest. Russian sample differed from the 
others by having the lowest frequency of diabetes, history 
of cancer, users of vitamin C supplement, but the highest 
frequency of history of CVD.
Distribution of gender-specific baseline characteristics 
across quintiles of vitamin C, vitamin E and beta-carotene 
intakes is presented in Table 2. In men, high dietary intake of 
antioxidant vitamins was related to higher age, higher educa-
tion, lower prevalence of smoking and alcohol consumption, 
lower caloric intake, use of vitamin C supplements and more 
frequent health problems (hypertension, diabetes and history 
of CVD). History of cancer in men was related to vitamin C 
intake but inversely related to vitamin E and beta-carotene 
intake. Women with high vitamin C intake were younger, 
better educated, more likely to consume alcohol, consume 
more calories and vitamin C supplements, healthier and had 
lower BMI, while women with high vitamin E and beta-car-
otene intake were older, less likely to smoke and drink alco-
hol and more likely to have health problems.
All‑cause mortality
Gender-specific HRs and 95 % CI for all-cause mortality 
by quintiles of antioxidant vitamin intakes in the pooled 
sample are presented in Table 3. In men, inverse associa-
tion between intake of vitamin C and all-cause mortality 
was observed but in a nonlinear manner. In the country-
pooled analysis, risk of death was lower by 28 % in men 
in third quintile of vitamin C intake and by 20 % in fourth 
quintile compared with the bottom quintile. The strongest 
protective effect of vitamin C was seen for men in Novo-
sibirsk (Supplementary Table I). Vitamin E intake was not 
associated with all-cause mortality in men, while beta-car-
otene consumption was associated with better survival only 
in men in Krakow.
In women, in the fully adjusted model, inverse U-shaped 
association between intake of vitamin E and all-cause mor-
tality was observed. Women in third quintile had 33 % less 
risk of mortality, and those in fourth quintile had 23 % less 
risk than the lowest intake group. In pooled data, vitamin C 
and beta-carotene intake was not associated with all-cause 
mortality in women.
CVD mortality
Gender-specific HRs and 95 % CI for CVD mortality by 
quintiles of antioxidant vitamin are presented in Table 4. 
In men, in the fully adjusted model of pooled data, higher 
intake of vitamin C was related to a modest decrease in 
CVD mortality risk; the risk was lower by 35 % in third 
quintile and by 23 % in fourth quintile compared with the 
bottom group. A beneficial effect of vitamin C was particu-
larly observed in men in Novosibirsk (Supplementary Table 
II). Vitamin E was not related to CVD mortality in men in 
pooled data. Beta-carotene intake (in second quintile) was 
related to the decrease in CVD mortality in men in Czech 
towns only (Supplementary Table II). In women, no signifi-
cant associations were observed between vitamin intakes 
and CVD mortality.
Cancer mortality
Cancer mortality by quintiles of antioxidant vitamins is 
presented in Table 5. In the fully adjusted model, there 
were no significant associations, neither in men, nor in 
women. In country-specific models in men (Supplemen-
tary Table III), vitamin C was significantly related to lower 
risk of cancer death by 46 and by 38 % in third quintile in 
Novosibirsk and in Krakow, respectively.
In our study, only 14 % of participants reported using 
any form of vitamin C supplementation. Exclusion of users 
of vitamin C supplements had no influence on the associa-
tions between antioxidant vitamins and mortality (Supple-
mentary tables IV, V and VI). Exclusion of early deaths 
or those with history of CVD or cancer at baseline did not 
affect the results (data not shown).
Discussion
This study, in three large urban population-based cohorts in 
CEE, did not find a strong evidence for a protective effect 
of antioxidant vitamin intake. There was some suggestion 
of protective effects in several subgroups (e.g., in men with 
moderate vitamin C intake and in women with moderate 
dietary intake of vitamin E), but the associations did not 
follow a dose–response pattern.
Limitations and strengths of this study
There are some limitations that should be taken into 
account for the interpretation of our findings. First, selected 
samples were representative only for urban populations of 
Czech Republic, Russia and Poland. The overall response 
rate in the HAPIEE study was modest but similar to those 
in other contemporary cohort studies [1]. Second, we were 
not able to include a quantitative assessment of vitamin 
supplements, and the lack of such information may bias 
our findings. However, we controlled for vitamin C supple-
ments use in the multivariable analyses and further stratifi-
cation of the analysis according to this variable revealed in 
no substantial change in our results.
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Third, although we controlled for the most important 
covariates, additional confounding factors may exist. Vita-
min intake may be correlated with overall diet quality, 
physical activity and socioeconomical status (other than 
education), and we cannot exclude the possibility that the 
beneficial effects of vitamins may be mediated by more 
complex and multifactorial mechanisms. A further weak-
ness of the study is that we did not adjust the results for 
the intake of saturated fatty acids; however, this effect was 
partially controlled by adjustment for total energy intake, 
which is strongly correlated with saturated fat intake. 
Finally, the use of FFQ may lead to an overestimation of 
some healthy foods, such as fruits and vegetables, and an 
underreporting of fats and oil intake, which in turn may 
result in overestimating vitamin C and beta-carotene con-
sumption and underestimating vitamin E intake.
On the other hand, the major strength of the present 
study is its large size and prospective design. To the best 
of our knowledge, this is the first prospective study in 
CEE countries which has explored the relation between 
dietary antioxidant vitamin intakes and mortality in large 
cohorts. Detailed and reliable assessment of individual 
diet was made; moreover, FFQ data were validated against 
plasma biomarkers in a substudy [34]. Analyses were con-
ducted separately for men and women. Associations stayed 
unchanged after exclusion of people with history of CVD 
or cancer at baseline, or early death (first 2 years of follow-
up) or users of vitamin C supplements. Furthermore, the 
study was done in samples with different exposure to other 
cardiovascular risk factors compared to Western Europe. 
For example, we found high prevalence of smoking, binge 
drinking and unhealthy diet, and weak association between 
education and economic position in our cohorts [1, 2, 28, 
29, 31, 33].
Interpretation of the results
Our results are consistent to some extent with previously 
published observational studies. In some cohorts, dietary 
intake of vitamin C was inversely associated with total and 
CVD mortality [7, 15–17, 38–40], but other studies did not 
observe such association [19, 20]. Excess vitamin C con-
sumed is excreted from the body [21, 41]. Experimental 
studies reported that very high concentration of vitamin C 
does not necessarily exert health benefits, instead may have 
potential harmful effects due to its pro-oxidant side effect 
Table 3  Age and multivariable-
adjusted HR (95 % CI) of 
all-cause mortality in men and 
women according to quintiles of 
vitamin intakes
a
 Adjusted to: age, country
b
 Adjusted to: age, country, education, smoking status, alcohol intake, BMI, hypertension, diabetes, hyper-
cholesterolemia, history of CVD or cancer, total energy intake
c
 Significant heterogeneity between cohorts was found, see also Supplementary Table I for country-spe-
cific results
Quintiles of vitamin intake
1 (low) 2 3 4 5 (high)
Men
Vitamin C
 Model 1a 1 0.85 (0.73–0.98) 0.62 (0.53–0.74) 0.68 (0.58–0.80) 0.78 (0.67–0.92)
 Model 2b 1 0.93 (0.80–1.08) 0.72 (0.61–0.85) 0.80 (0.68–0.95) 0.92 (0.78–1.09)
Vitamin E
 Model 1a 1 0.97 (0.83–1.15) 0.97 (0.83–1.15) 1.02 (0.87–1.20) 1.14 (0.97–1.34)
 Model 2b 1 0.98 (0.83–1.15) 0.98 (0.83–1.15) 1.02 (0.87–1.20) 1.08 (0.92–1.27)
Beta-carotenec
 Model 1a 1 0.88 (0.70–1.11) 0.94 (0.69–1.26) 0.89 (0.70–1.14) 1.02 (0.84–1.23)
 Model 2b 1 0.91 (0.75–1.10) 0.96 (0.69–1.33) 0.87 (0.68–1.12) 0.99 (0.83–1.17)
Women
Vitamin C
 Model 1a 1 0.81 (0.65–1.01) 0.90 (0.72–1.12) 0.78 (0.62–0.99) 0.76 (0.60–0.97)
 Model 2b 1 0.85 (0.68–1.06) 1.00 (0.80–1.26) 0.91 (0.72–1.15) 0.91 (0.71–1.16)
Vitamin E
 Model 1a 1 0.80 (0.65–0.99) 0.66 (0.52–0.83) 0.74 (0.59–0.93) 0.84 (0.66–1.06)
 Model 2b 1 0.85 (0.69–1.06) 0.67 (0.53–0.84) 0.77 (0.61–0.97) 0.85 (0.67–1.08)
Beta-carotene
 Model 1a 1 0.97 (0.77–1.20) 0.87 (0.69–1.09) 0.86 (0.68–1.08) 0.88 (0.70–1.10)
 Model 2b 1 1.03 (0.83–1.29) 0.93 (0.74–1.17) 0.93 (0.74–1.18) 0.86 (0.68–1.08)
Eur J Nutr 
1 3
[42]. Indeed, under certain conditions, such as the pres-
ence of free transition metals, vitamin C may function as 
a pro-oxidant [43]. This may explain partially that in our 
analysis, we did not find a dose–response effect of vitamin 
C intake and mortality.
Potential mechanisms that may explain the beneficial 
effect of vitamin C intake on mortality were postulated. 
Vitamin C was found to protect vascular endothelium, pre-
venting uncontrolled vascular smooth muscle cells prolifer-
ation, and inhibit the effects of pro-inflammatory cytokines 
and adhesion molecules which are important in atherogen-
esis [4]. However, in the present study, we did not observe 
clear inverse associations between dietary vitamin C intake 
and all-cause or CVD mortality. There was an indication 
of protective effect of moderate intake in men, but not in 
women; this could be partly explained by the small number 
of female deaths. Further, women in our cohort had higher 
mean intake of vitamin C than men, and consequently, the 
threshold for the lowest quintile (the highest risk) was also 
higher. Indeed, if the same cutoff points were adopted for 
both sexes, the results in women were closer to results in 
men. However, there were differences in the number of 
deaths in some groups, which affected the statistical power 
of these analyses. In contrast to our results, in a Japanese 
cohort study, dietary vitamin C was related to lower risk of 
CVD death in women only [17]. Results from other studies 
on dietary vitamin C and CVD mortality are inconsistent. 
With a few exceptions [7, 18], cohort studies in men and 
women combined failed to find an association for dietary 
vitamin C [19, 44, 45].
In women, we observed lower risk of all-cause mortality 
in the groups with moderate vitamin E consumption. While 
in most individual cohort studies, dietary consumption of 
vitamin E was not related to all-cause and CVD mortality 
[7, 17, 19–21, 38, 44], a meta-analysis of nine prospective 
studies indicated that vitamin E intake may be inversely 
related to CHD risk in women [45]. In another system-
atic review, high intake of tocopherol was associated with 
reduction in fatal and non-fatal cardiovascular events [18]. 
The evidence was supported by the postulated mechanisms. 
Vitamin E is a group of eight structurally related isomers of 
which alpha-tocopherol is the most biologically active. This 
fat-soluble antioxidant protects lipids from peroxidation 
and is able to scavenge mutagenic-free radicals and inhibit 
the oxidation of LDL cholesterol [3, 6]. Besides its anti-
oxidant features, tocopherols are also inhibitors of platelet 
Table 4  Age and multivariable-
adjusted HR (95 % CI) of 
CVD mortality in men and 
women according to quintiles of 
vitamin intakes
a
 Adjusted to: age, country
b
 Adjusted to: age, country, education, smoking status, alcohol intake, BMI, hypertension, diabetes, hyper-
cholesterolemia, history of CVD or cancer, total energy intake
c
 Significant heterogeneity between cohorts was found, see also Supplementary Table II for country-spe-
cific results
Quintiles of vitamin intake
1 (low) 2 3 4 5 (high)
Men
Vitamin C
 Model 1a 1 0.90 (0.73–1.11) 0.58 (0.45–0.75) 0.66 (0.51–0.85) 0.83 (0.65–1.06)
 Model 2b 1 0.98 (0.79–1.22) 0.65 (0.50–0.84) 0.77 (0.59–0.99) 0.94 (0.74–1.21)
Vitamin E
 Model 1a 1 0.95 (0.72–1.23) 0.96 (0.74–1.25) 1.09 (0.85–1.41) 1.33 (1.04–1.41)
 Model 2b 1 0.95 (0.72–1.23) 0.93 (0.72–1.21) 1.07 (0.83–1.38) 1.20 (0.93–1.54)
Beta-carotenec
 Model 1a 1 0.74 (0.58–0.96) 0.94 (0.66–1.35) 0.93 (0.74–1.18) 1.00 (0.79–1.26)
 Model 2b 1 0.76 (0.58–0.98) 0.95 (0.65–1.39) 0.90 (0.71–1.14) 0.92 (0.73–1.16)
Women
Vitamin C
 Model 1a 1 0.72 (0.51–1.00) 0.84 (0.60–1.19) 0.73 (0.51–1.06) 0.72 (0.49–1.05)
 Model 2b 1 0.75 (0.53–1.05) 0.93 (0.66–1.32) 0.86 (0.60–1.25) 0.87 (0.59–1.28)
Vitamin E
 Model 1a 1 0.82 (0.58–1.17) 0.82 (0.57–1.17) 0.73 (0.50–1.07) 0.81 (0.56–1.18)
 Model 2b 1 0.86 (0.60–1.23) 0.81 (0.56–1.16) 0.76 (0.52–1.11) 0.81 (0.55–1.18)
Beta-carotene
 Model 1a 1 0.95 (0.66–1.36) 0.87 (0.61–1.25) 0.68 (0.46–1.00) 0.89 (0.62–1.27)
 Model 2b 1 1.01 (0.70–1.46) 0.95 (0.66–1.37) 0.73 (0.49–1.08) 0.85 (0.59–1.23)
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aggregation and thrombus formation [46]. Observed asso-
ciations between vitamin E intake and mortality in women 
were in line with findings of higher lipid peroxidation in 
women and the possibility that females may have less com-
peting risk factors than men [45].
In the 15-year study of Dutch elderly men, higher caro-
tenes intake was related to about 20 % lower risk of CVD 
death [44]. In our study, dietary beta-carotene was not asso-
ciated with mortality. Similar results were found in a Dan-
ish study [20], in USA cohorts [7, 19] and in a meta-analy-
sis of nine prospective studies [45].
Despite antioxidant vitamins being postulated to play a 
role in the prevention of DNA damage induced by oxidation 
neutralizing potentially mutagenic ROS [6], we found no 
associations between dietary antioxidant vitamins and can-
cer mortality, which is consistent with other studies [7, 19].
In the interpretation of our results, it is important to 
take into account of the fact that mortality rates declined, 
and consumption of fruits, vegetables and vegetable oils 
increased in CEE countries over the last two decades. 
In consequence, nowadays, it may be more difficult to 
detect any relationship. However, according to the EFSA 
recommendation [47], in our sample, the proportion of 
participants with inadequate vitamin C intake was 37 % 
in men and 24 % in women. Regarding vitamin E, locally 
recommended intake (10 mg/day for men and 8 mg/day 
for women [9], was not reached by about 60 % of men and 
40 % of women.
Experimental studies provide convincing evidence that 
supplementation by antioxidant vitamins does not influ-
ence the risk of CVD and all-cause mortality. In this light, 
it could be argued that findings from ours and other cohort 
studies seem to reflect not an effect of vitamin consump-
tion but rather confounding by unknown factors. However, 
it is also possible that dietary intake of vitamins may be a 
marker of the other important dietary ingredients, and the 
U-shape relationship can be explained by the fact that par-
ticipants in the top quintiles had consumption of antioxi-
dant vitamins over the recommended amounts which was 
not related to additional benefits.
Conclusion
Results of the present study in CEE urban populations 
suggest there is no strong, dose-dependent relationship 
Table 5  Age and multivariable-
adjusted HR (95 % CI) of 
cancer mortality in men and 
women according to quintiles of 
vitamin intakes
a
 Adjusted to: age, country
b
 Adjusted to: age, country, education, smoking status, alcohol intake, BMI, hypertension, diabetes, hyper-
cholesterolemia, history of CVD or cancer, total energy intake
c
 Significant heterogeneity between cohorts was found, see also Supplementary Table III for country-spe-
cific results
Quintiles of vitamin intake
1 (low) 2 3 4 5 (high)
Men
Vitamin C
Model 1a 1 0.85 (0.65–1.13) 0.68 (0.51–0.92) 0.76 (0.57–1.01) 0.88 (0.66–1.16)
Model 2b 1 0.96 (0.73–1.26) 0.82 (0.61–1.11) 0.91 (0.68–1.23) 1.10 (0.82–1.46)
Vitamin E
Model 1a 1 0.96 (0.74–1.25) 0.92 (0.71–1.21) 0.86 (0.65–1.14) 0.89 (0.67–1.18)
Model 2b 1 0.97 (0.75–1.26) 0.98 (0.75–1.28) 0.88 (0.67–1.17) 0.91 (0.69–1.22)
Beta-carotene
Model 1a 1 0.74 (0.56–0.97) 0.90 (0.69–1.18) 0.77 (0.58–1.01) 0.84 (0.63–1.11)
Model 2b 1 0.78 (0.60–1.03) 0.94 (0.72–1.23) 0.80 (0.60–1.06) 0.88 (0.66–1.16)
Women
Vitamin Cc
Model 1a 1 0.88 (0.62–1.25) 0.94 (0.52–1.72) 0.93 (0.51–1.71) 1.03 (0.58–1.84)
Model 2b 1 0.93 (0.65–1.32) 0.98 (0.59–1.65) 1.03 (0.55–1.94) 1.07 (0.59–1.93)
Vitamin E
Model 1a 1 0.85 (0.60–1.19) 0.73 (0.51–1.06) 0.87 (0.60–1.26) 1.01 (0.69–1.47)
Model 2b 1 0.91 (0.64–1.28) 0.73 (0.51–1.06) 0.89 (0.61–1.28) 1.00 (0.69–1.47)
Beta-carotene
Model 1a 1 0.84 (0.59–1.19) 0.81 (0.57–1.16) 0.88 (0.61–1.26) 0.93 (0.65–1.34)
Model 2b 1 0.85 (0.60–1.21) 0.83 (0.58–1.18) 0.92 (0.63–1.33) 0.93 (0.65–1.34)
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between dietary intake of vitamin C, vitamin E and beta-
carotene and all-cause, CVD or cancer mortality. These 
findings are consistent with negative results of experimen-
tal studies on vitamin supplementation. The apparent ben-
eficial health effects of antioxidant rich foods, which were 
observed in other studies, may have explanations other than 
antioxidant vitamin intake.
Acknowledgments The HAPIEE study has been funded by the 
Wellcome Trust (Grants 064947/Z/01/Z and 081081/Z/06/Z), US 
National Institute on Ageing (Grant 1R01 AG23522-01) and the Mac-
Arthur Foundation Initiative on Social Upheaval and Health (award 
71208). D. Stefler was funded by the British Heart Foundation. 
Authors are grateful to all investigators of the HAPIEE Project and to 
participants of the surveys.
Conflict of interest The authors declare that they have no conflict 
of interest.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution License which permits any use, distribu-
tion, and reproduction in any medium, provided the original author(s) 
and the source are credited.
References
 1. Vandenheede H, Vikhireva O, Pikhart H, Kubinova R, Malyutina 
S, Pajak A et al (2014) Socioeconomic inequalities in all-cause 
mortality in the Czech Republic, Russia, Poland and Lithuania in 
the 2000s: findings from the HAPIEE Study. J Epidemiol Com-
munity Health 68:297–303
 2. Boylan S, Welch A, Pikhart H, Malyutina S, Pajak A, Kubinova 
R et al (2009) Dietary habits in three Central and Eastern Euro-
pean countries: the HAPIEE study. BMC Public Health 9:439. 
doi:10.1186/1471-2458-9-439
 3. Peng C, Wang X, Chen J, Jiao R, Wang L, Li YM, Zuo Y, Liu 
Y, Lei L, Ma KY, Huang Y, Chen ZY (2014) Biology of ageing 
and role of dietary antioxidants. Biomed Res Int. 2014:831–841. 
doi:10.1155/2014/831841
 4. Grosso G, Bei R, Mistretta A, Marventano S, Calabrese G, Mas-
uelli L, Giganti MG, Modesti A, Galvano F, Gazzolo D (2013) 
Effects of vitamin C on health: a review of evidence. Front 
Biosci (Landmark Ed) 18:1017–1029
 5. Reifen R (2002) Vitamin A as an anti-inflammatory agent. Proc 
Nutr Soc 61:397–400
 6. Traber MG, Stevens JF (2011) Vitamins C and E: beneficial 
effects from a mechanistic perspective. Free Radic Biol Med 
51:1000–1013
 7. Sahyoun NR, Jacques PF, Russel RM (1996) Carotenoids, vita-
mins C and E, and mortality in an eldery population. Am J Epi-
demiol 144:501–511
 8. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson 
JE, Willett WC (2003) Dietary carotenoids and risk of coronary 
artery disease in women. Am J Clin Nutr 77:1390–1399
 9. Jarosz M (2012) Dietary reference intakes for the Polish popula-
tion—amendment, in Polish. Natl Food Nutr Inst, Warsaw
 10. Landete JM (2013) Dietary intake of natural antioxidants: vita-
mins and polyphenols. Crit Rev Food Sci Nutr 53:706–721
 11. Boeing H, Bechthold A, Bub A, Ellinger S, Haller D, Kroke A 
et al (2012) Critical review: vegetables and fruit in the preven-
tion of chronic diseases. Eur J Nutr 51:637–663
 12. Bjelakovic G, Nikolova D, Gluud C (2013) Meta-regression anal-
yses, meta-analyses, and trial sequential analyses of the effects 
of supplementation with beta-carotene, vitamin A, and vitamin 
E singly or in different combinations on all-cause mortality: 
do we have evidence for lack of harm? PLoS ONE 8:e74558. 
doi:10.1371/journal.pone.0074558
 13. Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ 
(2011) Vitamin E and all-cause mortality: a meta-analysis. Curr 
Aging Sci 4:158–170
 14. Van Hoydonck PG, Temme EH, Schouten EG (2002) A dietary 
oxidative balance score of vitamin C, beta-carotene and iron 
intakes and mortality risk in male smoking Belgians. J Nutr 
132:756–761
 15. Bates CJ, Hamer M, Mishra GD (2011) Redox-modulatory vita-
mins and minerals that prospectively predict mortality. Br J Nutr 
105:123–132. doi:10.1017/S0007114510003053
 16. Yochum LA, Folsom AR, Kushi LH (2000) Intake of antioxi-
dant vitamins and risk of death from stroke in postmenopausal 
women. Am J Clin Nutr 72:476–483
 17. Kubota Y, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, Inaba 
Y, Tamakoshi A, JACC Study Group (2011) Dietary intakes of 
antioxidant vitamins and mortality from cardiovascular disease: 
the Japan collaborative cohort study (JACC). Study 42:1665–
1672. doi:10.1161/STROKEAHA.110.601526
 18. Asplund K (2002) Antioxidant vitamins in the prevention of 
cardiovascular disease: a systematic review. J Intern Med 
251:372–392
 19. Genkinger JM, Platz EA, Hoffman SC, Comstock GW, Helzl-
souer KJ (2004) Fruit, vegetable, and antioxidant intake and all-
cause, cancer, and cardiovascular disease mortality in a commu-
nity-dwelling population in Washington County, Maryland. Am J 
Epidemiol 160:1223–1233
 20. Roswall N, Olsen A, Christensen J, Hansen L, Dragsted LO, 
Overvad K, Tjønneland A (2012) Micronutrient intake in relation 
to all-cause mortality in a prospective Danish cohort. Food Nutr 
Res. doi:10.3402/fnr.v56i0.5466
 21. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner 
B, Willett WC (1993) Vitamin E consumption and the risk of 
coronary disease in women. N Engl J Med 328:1444–1449
 22. Fletcher AE, Breeze E, Shetty PS (2003) Antioxidant vitamins 
and mortality in older persons: findings from the nutrition add-
on study to the Medical Research Council Trial of Assessment 
and Management of Older People in the Community. Am J Clin 
Nutr 78:999–1010
 23. Jain M, Miller AB, To T (1994) Premorbid diet and the prognosis 
of women with breast cancer. J Natl Cancer Inst 86:1390–1397
 24. Cui X, Rosner B, Willett WC, Hankinson SE (2011) Anti-
oxidant intake and risk of endometrial cancer: results from the 
Nurses’ Health Study. Int J Cancer 128:1169–1178. doi:10.1002/
ijc.25425
 25. Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim 
S (2004) Those confounded vitamins: what can we learn from 
the differences between observational versus randomised trial 
evidence? Lancet 363:1724–1727
 26. Novaković R, Cavelaars AE, Bekkering GE, Roman-Viñas B, 
Ngo J, Gurinović M, Glibetić M et al (2012) Micronutrient intake 
and status in Central and Eastern Europe compared with other 
European countries, results from the EURRECA network. Public 
Health Nutr 16:824–840. doi:10.1017/S1368980012004077
 27. Waskiewicz A, Sygnowska E (2009) Vitamins and minerals 
intake from diet and supplements among subjects with a history 
of cardiovascular events in Polish population. Rocz Panstw Zakl 
Hig 60:275–278
 28. Zaton´ski W, Przewozniak K, Sulkowska U, West R, Wojtyła A 
(2012) Tobacco smoking in countries of the European Union. 
Ann Agric Environ Med 19:181–192
 Eur J Nutr
1 3
 29. Pajak A, Szafraniec K, Kubinova R, Malyutina S, Peasey A, 
Pikhart H, Nikitin Y, Marmot M, Bobak M (2013) Binge drink-
ing and blood pressure: cross-sectional results of the HAPIEE 
study. PLoS ONE 8:e65856. doi:10.1371/journal.pone.0065856
 30. Poledne R, Skodowa Z (2000) Changes in nutrition, choles-
terol concentration, and cardiovascular disease mortality in the 
Czech population in the past decade. Nutrition 16:785–786. 
doi:10.1016/S0899-9007(00)00390-7
 31. Paalanen L, Prättälä R, Alfthan G, Salminen I, Laatikainen T 
(2013) Vegetable and fruit consumption, education and plasma 
vitamin C concentration in Russian and Finnish Karelia, 
1992–2002. Public Health Nutr 17:2278–2286. doi:10.1017/
S1368980013002243
 32. Zatonski W, Campos H, Willett W (2008) Rapid declines in cor-
onary heart disease mortality in Eastern Europe are associated 
with increased consumption of oils rich in alpha-linolenic acid. 
Eur J Epidemiol 23:3–10
 33. Peasey A, Bobak M, Kubinowa R, Malyutina S, Pajak A, Tamo-
siunas A et al (2006) Determinants of cardiovascular disease 
and other non-communicable diseases in Central and Eastern 
Europe: rationale and design of the HAPIEE study. BMC Public 
Health 6:255. doi:10.1186/1471-2458-6-255
 34. Stefler D, Pikhart H, Jankovic N, Kubinova R, Pajak A, Maly-
utina S, Simonova G, Feskens EJ, Peasey A, Bobak M (2014) 
Healthy diet indicator and mortality in Eastern European popula-
tions: prospective evidence from the HAPIEE cohort. Eur J Clin 
Nutr. doi:10.1038/ejcn.2014.134
 35. Henriquez-Sanchez P, Sanchez-Villegas A, Doreste-Alonso J, 
Ortiz-Andrellucchi A, Pfrimer K, Serra-Majem L (2009) Die-
tary assessment methods for micronutrient intake: a systematic 
review on vitamins. Br J Nutr 102(10–37 Suppl):1. doi:10.1017/
S0007114509993126
 36. Hosmer D, Lomeshow S (1999) Applied survival analysis. Wiley, 
New York
 37. Willett WC, Howe GR, Kushi LH (1997) Adjustment for 
total energy intake in epidemiologic studies. Am J Clin Nutr 
65:1220S–1228S
 38. Agudo A, Cabrera L, Amiano P, Ardanaz E, Barricarte A, 
Berenguer T et al (2007) Fruit and vegetable intakes, dietary 
antioxidant nutrients, and total mortality in Spanish adults: find-
ings from the Spanish cohort of the European prospective inves-
tigation into cancer and nutrition (EPIC-Spain). Am J Clin Nutr 
85:1634–1642
 39. Kromhout D, Bloemberg B, Feskens E, Menotti A, Nissinen A 
(2000) Saturated fat, vitamin C and smoking predict long-term 
population all-cause mortality rates in the seven countries study. 
Int J Epidemiol 29:260–265
 40. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J (1995) 
Dietary vitamin C and beta-carotene and risk of death in mid-
dle-aged men. The Western Electric Study. Am J Epidemiol 
142:1269–1278
 41. Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH et al 
(2003) Vitamin C as an antioxidant: evaluation of its role in dis-
ease prevention. J Am Coll Nutr 22:18–35
 42. Duarte TL, Lunec J (2005) Review: when is an antioxidant not an 
antioxidant? A review of novel actions and reactions of vitamin 
C. Free Radic Res 39:671–686
 43. Buettner GR, Jurkiewicz BA (1996) Catalytic metals, ascor-
bate and free radicals: combinations to avoid. Radiat Res 
145:532–541
 44. Buijsse B, Feskens EJ, Kwape L, Kok FJ, Kromhout D (2008) 
Both a- and b-carotene, but not tocopherols and vitamin C, are 
inversely related to 15-year cardiovascular mortality in Dutch 
elderly men. J Nutr 138:344–350
 45. Knekt P, Ritz J, Pereira MA, O’Reilly EJ, Augustsson K, Fraser 
GE et al (2004) Antioxidant vitamins and coronary heart dis-
ease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 
80:1508–1520
 46. Dragsted LO (2008) Biomarkers of exposure to vitamins A, C, 
and E and their relation to lipid and protein oxidation markers. 
Eur J Nutr 47:3–18
 47. European Food Safety Authority NDA Panel (2013) Scien-
tific opinion on dietary reference values for vitamin C. EFSA J 
11:3418. doi:10.2903/j.efsa.2013.3418
